# Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient Department

> **NCT06683053** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Conrado Roberto Hoffmann Filho** · enrollment: 90 (actual)

## Conditions studied

- Congestive Heart Failure (CHF)

## Interventions

- **DRUG:** empagliflozin

## Key facts

- **NCT ID:** NCT06683053
- **Lead sponsor:** Conrado Roberto Hoffmann Filho
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-03-17
- **Primary completion:** 2024-04-29
- **Final completion:** 2025-02-28
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06683053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06683053, "Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient Department". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06683053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*